FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
NBMBX
Price
$15.23
Change
+$0.15 (+0.99%)
Updated
Aug 21 closing price
Net Assets
2.23B
Interact to see
Advertisement

FSMAX vs NBMBX

FSMAX vs NBMBX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. NBMBX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and NBMBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. NBMBX (2.23B). FSMAX pays higher dividends than NBMBX: FSMAX (0.50) vs NBMBX (0.00). FSMAX was incepted earlier than NBMBX: FSMAX (15 years) vs NBMBX (30 years). NBMBX (1.18) is less costly to investors than FSMAX (0.04). NBMBX is a more actively managed with annual turnover of: 144.00 vs. FSMAX (23.00). FSMAX (0) and NBMBX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. NBMBX (-18.65). FSMAX return over 5 years is better than : 40.14 vs. NBMBX (-32.05).
FSMAXNBMBXFSMAX / NBMBX
Total Expense Ratio0.041.183%
Annual Report Gross Expense Ratio0.041.183%
Fund Existence15 years30 years-
Gain YTD16.9374.101413%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B2.23B1,797%
Annual Yield % from dividends0.500.00-
Returns for 1 year23.68-18.65-127%
Returns for 3 years72.747.83929%
Returns for 5 years40.14-32.05-125%
Returns for 10 years134.4912.401,085%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPXX19.080.09
+0.47%
Nuveen S&P 500 Dynamic Overwrite Fund
FBDC17.67N/A
-0.01%
FT Confluence BDC & SpecialtyFinacIncETF
CALI50.38-0.01
-0.03%
iShares Short-Term CA Muni Act ETF
WEA10.43-0.05
-0.48%
Western Asset Premier
BIS10.82-0.30
-2.70%
ProShares UltraShort Nasdaq Biotech